Patents by Inventor Eugene Kern

Eugene Kern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130328395
    Abstract: A power plant, in the form of a combined heat and power (CHP) plant, may be co-located with a data center to provide redundant electrical power. The CHP plant and the data center may operate as an island, separate from the local electrical-utility grid. The CHP plant may have a redundant fuel source connection to reduce unavailability of fuel for the CHP and increase the uptime of the data center. The CHP plant may include turbines and engines to manage variable loads within the data center. The power plant may include multiple distributions busses in high-availability configurations to provide highly-reliable and high-quality electricity to the data center. The positioning of these elements in the power plant design provides economies of scale and eliminates single points of failure commonly found in data center configurations, increasing the reliability of the data center.
    Type: Application
    Filed: June 4, 2013
    Publication date: December 12, 2013
    Inventors: Robert Krizman, Earl Eugene Kern
  • Patent number: 6416955
    Abstract: The invention provides methods and materials related to the diagnosis of eosinophil degranulating conditions. Specifically, the invention provides methods and materials that involve visual types of analysis (e.g., microscopic analysis) that are used to determine the presence or absence of a horseshoe-shaped eosinophil granule structure within a mucus sample collected from a mammal. The presence of a horseshoe-shaped eosinophil granule structure within a patient's mucus indicates that the patient has an eosinophil degranulating condition. In addition, the invention provides methods and materials that involve immunological types of analysis (e.g., immunoassays) that are used to determine if a patient's mucus contains a tissue-damaging amount of eosinophil granule content that is outside the eosinophil granule and within the mucus.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: July 9, 2002
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: David Sherris, Eugene Kern, Jens Ponikau, Hirohito Kita